|
Variables
|
Group D (N = 18)
|
Group ND (N = 25)
|
P-values
|
|---|
|
Treatment received
|
14
|
23
|
0.378
|
|
Deterioration (discontinue treatment)
|
4
|
2
| |
|
Medication
|
|
-Amphotericin B then itraconazole
|
5
|
6
|
1.000
|
|
-Itraconazole
|
4
|
2
|
0.378
|
|
-Fluconazole then itraconazole
|
4
|
10
|
0.220
|
|
-Voriconazole
|
1
|
5
|
0.367
|
|
Outcome, n (%)
|
0.022*
|
|
-Cure
|
5 (27.78)
|
13 (52 %)
| |
|
-Recovery
|
6 (33.33 %)
|
7 (28 %)
| |
|
-Dead
|
8 (44.44 %)
|
3 (12 %)
| |
- Patients with Penicillium marneffei infection were divided into two groups; Group D included patients with underlying disease, and Group ND included patients without underlying disease
- *P < 0.05
- Data are presented as the number of patients, unless otherwise indicated
